#1 Clinical Trials Search in Europe

Doxycycline Monohydrate

This article explores the use of Doxycycline Monohydrate in various clinical trials. These studies primarily focus on assessing the bioequivalence of different formulations of the drug under various conditions, such as fasting and fed states. Additionally, we’ll look at its potential application in treating certain medical conditions. The trials aim to compare the absorption rates and effectiveness of different brands and formulations of Doxycycline Monohydrate, providing valuable insights for both healthcare professionals and patients.

Table of Contents

What is Doxycycline Monohydrate?

Doxycycline Monohydrate is an antibiotic medication that belongs to the tetracycline class of drugs. It’s also known by brand names such as Monodox, Adoxa, and Vibramycin[1]. This medication is used to treat various bacterial infections and has been the subject of numerous clinical trials to evaluate its effectiveness and proper usage[2].

Medical Uses

Doxycycline Monohydrate is prescribed for several medical conditions, including:

  • Acne Vulgaris: It’s commonly used to treat moderate to severe acne. In some studies, it has been combined with other compounds like S-equol to enhance its effectiveness in treating acne[3].
  • Cutaneous T-cell Lymphoma (CTCL): This is a type of cancer affecting the skin. Ongoing research is evaluating the efficacy of Doxycycline in treating relapsed cases of CTCL, including specific types like Mycosis Fungoides and Sezary Syndrome[4].

While these are specific examples from the clinical trials, it’s important to note that Doxycycline is a broad-spectrum antibiotic, meaning it can be effective against a wide range of bacterial infections.

How It’s Administered

Doxycycline Monohydrate comes in various forms and dosages:

  • Capsules: Usually available in 50mg and 100mg strengths[5].
  • Tablets: Available in various strengths, including 100mg and 150mg[5].
  • Oral Suspension: For those who have difficulty swallowing pills, it’s available as a liquid suspension, typically 25mg per 5mL[1].

The dosage and duration of treatment depend on the specific condition being treated and the patient’s individual needs. For instance, in some acne studies, it was administered twice daily[3].

Bioequivalence Studies

Several studies have been conducted to compare different formulations of Doxycycline Monohydrate. These bioequivalence studies aim to ensure that different brands or formulations of the drug deliver the same amount of active ingredient to the body[6].

Bioequivalence is measured by comparing certain parameters:

  • Cmax: The maximum concentration of the drug in the blood
  • AUC: Area Under the Curve, which represents the total exposure to the drug over time

These studies help ensure that generic versions of the drug are as effective as brand-name versions[7].

Effects of Food on Absorption

The absorption of Doxycycline Monohydrate can be affected by food. Some studies have specifically looked at how the drug is absorbed under fasting conditions (when no food has been eaten) versus fed conditions (after a meal)[2].

In some cases, taking the medication with food might help reduce stomach upset, a common side effect. However, it’s important to follow your doctor’s or pharmacist’s instructions, as food can sometimes interfere with the absorption of certain medications[6].

Ongoing Research

Researchers continue to explore new uses for Doxycycline Monohydrate. For example, a study is investigating its potential in treating Cutaneous T-cell Lymphoma (CTCL), a type of skin cancer. This research aims to determine if Doxycycline could be an effective treatment for patients whose CTCL has returned after previous treatment[4].

Potential Side Effects

While the clinical trials data provided doesn’t extensively discuss side effects, it’s important to be aware that all medications can have potential side effects. Common side effects of Doxycycline may include:

  • Nausea or stomach upset
  • Sensitivity to sunlight
  • Headache

Always discuss potential side effects with your healthcare provider before starting any new medication.

Aspect Details
Main Focus Bioequivalence studies of Doxycycline Monohydrate formulations
Formulations Studied Tablets, capsules, oral suspensions
Conditions Fasting and fed states
Key Measurements Cmax, AUC (Area Under the Curve)
Dosages Ranging from 25mg to 150mg
Study Designs Mostly crossover studies with healthy volunteers
Treatment Potential Explored for Cutaneous T-cell Lymphoma (CTCL)
Duration Mostly single-dose studies; CTCL study up to one year
Outcomes Bioequivalence assessment, efficacy in CTCL, quality of life measures

FAQ

  • What is the main purpose of most Doxycycline Monohydrate clinical trials? Most of the clinical trials focus on assessing the bioequivalence of different formulations of Doxycycline Monohydrate. This means they compare how different versions of the drug are absorbed and processed by the body, ensuring that generic versions work as effectively as brand-name versions.
  • What conditions are being studied for Doxycycline Monohydrate treatment? While most trials focus on bioequivalence, one study explores the use of Doxycycline Monohydrate for treating Cutaneous T-cell Lymphoma (CTCL), including conditions like Mycosis Fungoides and Sezary Syndrome.
  • How do the trials compare different formulations of Doxycycline Monohydrate? The trials compare different formulations (such as tablets, capsules, and oral suspensions) by measuring factors like the maximum concentration of the drug in the blood (Cmax) and the area under the concentration-time curve (AUC), which indicates total drug exposure over time.
  • What are 'fed' and 'fasting' conditions in these trials? In these trials, 'fed' conditions mean the drug is taken after a meal, while 'fasting' conditions mean it's taken on an empty stomach. These different conditions can affect how the drug is absorbed by the body, so both are studied to ensure the drug works effectively in various situations.
  • What is the significance of bioequivalence in these studies? Bioequivalence is important because it ensures that generic versions of Doxycycline Monohydrate work just as well as brand-name versions. This can lead to more affordable treatment options for patients while maintaining the same level of effectiveness.

Ongoing Clinical Trials on Doxycycline Monohydrate

  • Study on Doxycycline for Reducing Bacterial STIs in MSM and TGW with HIV

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

  • Doxycycline for Asymptomatic Anal LGV Infection in Patients with Asymptomatic Anal LGV Infection

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on the Effects of Doxycycline for Preventing Antibiotic Resistance in Patients with Bacterial STDs (Chlamydia, Gonorrhea, Syphilis)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Germany Italy +4

  • Study on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Spain

  • Study Comparing Doxycycline and Benzathine Benzylpenicillin for Treating Early Syphilis in Adults

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Bioequivalence: The property of two drug products having the same rate and extent of absorption, making their effects essentially the same.
  • Cmax: The maximum concentration of a drug observed in the blood after administration.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, calculated from a graph of drug concentration in the blood versus time.
  • Doxycycline Monohydrate: An antibiotic medication used to treat various bacterial infections and, in some cases, being studied for other conditions.
  • Cutaneous T-cell Lymphoma (CTCL): A rare type of cancer that begins in T-cells (a type of white blood cell) and affects the skin.
  • Mycosis Fungoides: The most common form of Cutaneous T-cell Lymphoma, characterized by skin lesions that progress from patches to more serious forms.
  • Sezary Syndrome: An aggressive type of Cutaneous T-cell Lymphoma that affects both the skin and blood.
  • Crossover Study: A type of clinical trial where participants receive different treatments in a specific order, allowing comparison of effects within the same group of subjects.
  • Fasting Conditions: A state where a person has not eaten for a certain period, usually overnight, before taking a medication.
  • Fed Conditions: A state where a person has recently eaten a meal before taking a medication.

References

  1. https://clinicaltrials.gov/study/NCT00829790
  2. https://clinicaltrials.gov/study/NCT00652704
  3. https://clinicaltrials.gov/study/NCT01301586
  4. https://clinicaltrials.gov/study/NCT02341209
  5. https://clinicaltrials.gov/study/NCT00652795
  6. https://clinicaltrials.gov/study/NCT01380496
  7. https://clinicaltrials.gov/study/NCT00829764